Test may predict cognitive performance
MS and employment survey seeks participants
Study: Cladribine doesn’t pose cancer risk in MS patients
Experimental drug may spur myelin repair
FDA approves BETASERON electronic autoinjector
Researchers seek participants for MS, parenting study
Ocrelizumab effective in people with primary progressive MS
Antibody agitation may improve cognition
Unless otherwise specified, all medical content is compiled by MSF staff and reviewed for accuracy by a member of our Medical Advisory Board.
The MSF strives to present clear and unbiased information. This site is partially funded through a grant from Bayer Healthcare, LLC.
Website Design by SimplexWeb
© Copyright 2000-2013 Multiple Sclerosis Foundation - All Rights Reserved